We asked whether human breast cancer cells derived from an individual harbouring a BRCA1 germline mutation and complete loss of BRCA1 function (BRCA−/−) would have a specific chemosensitivity profile compared to the sporadic tumour-derived hormone-sensitive MCF-7 and hormone-insensitive MDA-MB231 cell lines. The gene discussed is BRCA1; the disease is breast cancer.